Trial intelligence / Profile preview

Combination Nutraceutical Kit for Muscle, Cognitive, and Immune Function in Older Adults

NCT07534878Phase 4Completed

Sponsor
Gplife Healthcare
Start
Dec 2025
Primary completion
Jan 2026
Countries
1
01

Overview

Phase 4, open-label, single-arm trial in functional decline in older adults and Mild Cognitive Impairment (MCI), sponsored by Gplife Healthcare. Primary endpoint: 6-minute walk test at Week 8. Started Dec 2025; status: completed.

02

Conditions

functional decline in older adultsMild Cognitive Impairment (MCI)

Beyond the preview

Go deeper on NCT07534878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07534878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call